background
numer
protocol
viral
enrich
genom
amplif
creat
howev
direct
identif
viral
genom
clinic
specimen
use
nextgener
sequenc
ng
still
challeng
select
viral
nucleic
acid
extract
method
may
determin
sensit
reliabl
ng
still
valuabl
evalu
extract
effici
differ
extract
kit
use
clinic
specimen
directli
result
studi
perform
qrtpcr
viral
metagenom
analysi
extract
effici
four
commonli
use
qiagen
extract
kit
qiaamp
viral
rna
mini
kit
vrmk
qiaamp
minelut
viru
spin
kit
mvsk
rneasi
mini
kit
rmk
rneasi
plu
micro
kit
rpmk
use
mix
respiratori
clinic
sampl
without
pretreat
sampl
contain
adenoviru
adv
influenza
viru
flu
human
parainfluenza
viru
human
coronaviru
human
metapneumoviru
hmpv
quantiti
qualiti
viral
extract
significantli
differ
among
kit
highest
threshold
cycl
ct
valu
adv
obtain
use
rpmk
mvsk
lowest
ct
valu
adv
rmk
reveal
lowest
detect
hmpv
effect
rate
ng
data
observ
rpmk
three
kit
rang
effect
rate
ng
data
importantli
compar
three
kit
highest
proport
nonhost
read
obtain
rpmk
mvsk
perform
best
lowest
ct
valu
extract
adv
rmk
reveal
best
extract
effici
ng
analysi
conclus
evalu
viral
nucleic
acid
extract
effici
differ
ng
qrtpcr
analysi
rpmk
applic
metagenom
analysi
viral
rna
enabl
sensit
identif
rna
viru
genom
respiratori
clinic
sampl
addit
viral
rna
extract
kit
also
applic
metagenom
analysi
dna
viru
result
highlight
import
nucleic
acid
extract
kit
select
major
impact
yield
number
viral
read
ng
analysi
therefor
choic
extract
method
given
viral
pathogen
need
care
consid
nextgener
sequenc
ng
attract
approach
diagnosi
infect
might
serv
great
potenti
method
identifi
virus
bacteria
fungi
rang
biolog
environment
sampl
clinic
diagnost
refer
lab
variou
ng
approach
provid
solut
detect
purifi
concentr
virus
cultur
howev
direct
identif
viral
genom
clinic
specimen
use
ng
method
still
challeng
includ
nois
host
microbiota
cell
limit
viral
rna
dna
quantiti
numer
protocol
viral
enrich
genom
amplif
describ
literatur
commonli
employ
protocol
sampl
filtrat
nucleas
digest
ultracentrifug
random
preamplif
rna
dna
separ
reaction
would
particularli
use
increas
signaltonois
ratio
viral
analysi
biolog
sampl
level
nucleic
acid
background
high
principl
protocol
significantli
reduc
proport
human
bacteria
read
increas
number
viral
read
fact
filtrat
nucleas
treatment
slightli
decreas
number
viru
read
number
virus
identifi
preamplif
use
random
rtpcr
result
detect
fewer
virus
overlap
sequenc
lower
genom
coverag
ampliconbas
ng
detect
predefin
target
thu
possibl
miss
virus
novel
viru
strain
apart
method
crucial
step
molecular
detect
virus
clinic
specimen
effici
extract
viral
nucleic
acid
higher
virusrel
yield
extract
meant
better
sensit
subsequ
detect
analysi
thu
extract
method
select
may
determin
sensit
reliabl
diagnost
ng
sampl
type
greatli
influenc
composit
sequenc
read
due
complex
clinic
materi
therefor
valuabl
use
nucleic
acid
extract
directli
clinic
specimen
without
enrich
evalu
extract
effici
studi
assess
viral
nucleic
acid
extract
effici
four
commonli
use
qiagen
kit
qiaamp
viral
rna
mini
kit
vrmk
qiaamp
minelut
viru
spin
kit
mvsk
rneasi
mini
kit
rmk
rneasi
plu
micro
kit
rpmk
among
vrmk
mvsk
rmk
describ
literatur
ngsbase
detect
use
respiratori
specimen
perform
kit
viral
nucleic
acid
extract
compar
regard
simultan
isol
viral
dna
rna
qrtpcr
analysi
number
read
contain
five
differ
virus
distribut
viral
sequenc
read
taxonom
categori
percentag
virusspecif
read
gener
sequenc
illumina
hiseq
system
evalu
parallel
use
ident
ng
process
bioinformat
analys
mix
sampl
two
nasopharyng
aspir
specimen
contain
adenoviru
adv
influenza
viru
flu
human
parainfluenza
viru
human
coronaviru
human
metapneumoviru
hmpv
without
pretreat
approach
virus
chosen
cover
wide
rang
differ
viral
properti
nonenvelop
dna
viru
adv
envelop
singlestrand
segment
rna
viru
flu
envelop
negativestrand
rna
viru
hmpv
envelop
positivestrand
rna
viru
fair
comparison
four
commerci
avail
viral
nucleic
acid
extract
kit
amount
start
sampl
elut
buffer
use
five
differ
virus
differ
characterist
chosen
flu
hmpv
adv
follow
nucleic
acid
extract
viru
elut
initi
quantifi
qrtpcr
determin
perform
kit
later
kit
two
parallel
librari
two
extract
aliquot
sampl
individu
gener
use
sequenc
protocol
bioinformat
analys
parallel
result
show
good
repeat
kit
see
addit
file
accord
qrtpcr
result
tabl
highest
ct
valu
adv
obtain
use
rpmk
flu
adv
hmpv
lower
ct
valu
achiev
vrmk
mvsk
lowest
ct
valu
adv
rmk
reveal
lowest
detect
hmpv
five
virus
show
detect
amount
viral
nucleic
acid
respect
sampl
except
flu
undetect
rpmk
nucleic
acid
concentr
dna
prepar
close
amount
theoret
requir
use
dna
librari
prep
kit
accord
manufactur
recommend
tabl
highest
dna
concentr
averag
found
sampl
extract
mvsk
extract
rpmk
result
lowest
averag
concentr
moder
dna
concentr
observ
vrmk
rmk
best
result
present
bold
illumina
sequenc
respect
librari
n
gener
total
million
pairedend
read
total
gbp
sequenc
inform
averag
percentag
base
qualiti
score
greater
tabl
amount
ng
data
exhibit
particularli
larg
differ
among
eight
sampl
read
pass
qualiti
filter
map
human
refer
genom
use
stringent
criteria
effect
rate
ng
data
observ
rpmk
tabl
three
kit
effect
rate
ng
data
rang
importantli
highest
proport
nonhost
read
obtain
rpmk
compar
three
kit
fig
shown
tabl
extract
effici
four
kit
five
virus
differ
align
refer
genom
sequenc
genbank
access
number
rpmk
gener
sequenc
breadth
coverag
nucleotid
pairwis
ident
highest
read
number
read
highest
coverag
hmpv
full
genom
sequenc
deposit
genbank
access
number
compar
rmk
genom
read
increas
contrast
lowest
read
coverag
adv
flu
obtain
use
rpmk
rmk
produc
highest
coverag
percentag
adv
consider
differ
among
four
kit
read
number
coverag
flu
read
coverag
proport
sequenc
read
signific
hit
virus
bacteria
unknown
human
entri
summar
fig
observ
improv
rate
viru
bacteria
detect
clinic
sampl
rpmk
extract
averag
read
classifi
known
virus
bacteria
human
respect
contrast
averag
valid
sequenc
classifi
virus
three
kit
limit
factor
nucleic
acid
extract
lower
pathogen
concentr
specimen
volum
could
result
insuffici
amount
ng
start
materi
therefor
increas
sampl
volum
effect
solut
viral
metagenom
analysi
order
improv
number
viru
read
genom
coverag
addit
increas
sequenc
capac
also
improv
chanc
viru
detect
although
use
massiv
throughput
ng
platform
may
increas
cost
use
still
reliabl
effect
method
studi
compar
extract
effici
four
commonli
use
qiagen
extract
kit
vrmk
mvsk
rpmk
rmk
use
amount
input
output
elut
sampl
contrast
use
cellcultur
refer
virus
studi
focus
ngsbase
detect
analysi
respiratori
clinic
specimen
evalu
perform
aforement
four
kit
ng
term
abil
kit
recov
sequenc
inform
five
differ
dna
rna
virus
clinic
sampl
ensur
reliabl
repeat
experiment
result
set
extract
n
kit
qrtpcr
assay
n
extract
ng
analysi
n
kit
duplic
rpmk
procedur
sampl
first
lyse
homogen
highli
denatur
guanidineisothiocyanatecontain
buffer
immedi
inactiv
rnase
ensur
isol
intact
rna
lysat
pass
gdna
elimin
spin
column
column
combin
optim
highsalt
buffer
effici
remov
tabl
remov
human
read
rpmk
effect
reduc
amount
human
read
dramat
increas
proport
viral
rna
bacteri
read
fig
even
obtain
full
genom
sequenc
thu
provid
suffici
sequenc
inform
confirm
viru
ident
whole
viral
genom
sequenc
also
inform
like
phenotyp
includ
drug
suscept
neutral
serotyp
may
prove
use
viral
transmiss
evolut
studi
best
knowledg
first
studi
viral
metagenom
analysi
respiratori
clinic
sampl
without
pretreat
approach
use
rpmk
interestingli
ratio
viral
read
coverag
obtain
ng
well
correl
ct
valu
sampl
highlight
import
necess
use
differ
method
evalu
extract
effici
qrtpcr
result
demonstr
qrtpcr
analysi
data
also
show
differ
kit
may
exhibit
differ
extract
effici
differ
virus
dramat
differ
ct
valu
observ
among
five
select
virus
tabl
pool
origin
ct
valu
adv
flu
hmpv
respect
lower
result
obtain
use
test
kit
studi
may
explain
use
autom
extract
platform
addit
carrier
rna
origin
extract
method
typic
way
increas
extract
yield
repeat
freezethaw
step
might
also
contribut
bia
appropri
kit
choic
crucial
factor
determin
experi
result
result
impli
suitabl
kit
perfect
viral
pathogen
choic
extract
method
given
viral
pathogen
need
care
consid
notabl
viral
rna
extract
kit
abl
isol
viral
dna
effect
vrmk
rpmk
rmk
design
viral
rna
extract
mvsk
viral
dna
rna
extract
accord
manufactur
recommend
compar
thee
kit
surpris
qrtpcr
analysi
mvsk
perform
best
lowest
ct
valu
extract
adv
dna
viru
vrmk
rpmk
rmk
achiev
moder
higher
ct
valu
respect
ng
analysi
result
place
extract
kit
order
decreas
extract
effici
follow
rmk
vrmk
mvsk
rpmk
indic
rmk
actual
suitabl
adv
identif
rather
mvsk
assum
viral
rna
extract
kit
also
applic
metagenom
analysi
dna
viru
probabl
effect
captur
rna
transcript
dna
viru
extract
clinic
sampl
result
provid
contrast
evid
previou
studi
report
evalu
four
differ
commerci
nucleic
acid
extract
kit
four
differ
virus
conclud
select
kit
minor
impact
yield
viral
read
read
number
obtain
ng
follow
factor
might
explain
differ
studi
previous
report
research
differ
extract
kit
test
virus
use
mix
aliquot
eggor
cellcultur
refer
virus
use
previou
work
mix
clinic
sampl
use
current
studi
extract
nucleic
acid
earlier
studi
divid
two
aliquot
one
aliquot
subject
dna
rna
process
ng
current
work
extract
nucleic
acid
treat
procedur
duplic
evalu
viral
nucleic
acid
extract
effici
differ
ng
qrtpcr
analysi
rpmk
applic
metagenom
analysi
viral
rna
enabl
sensit
identif
rna
viru
genom
respiratori
clinic
sampl
viral
rna
extract
kit
also
applic
metagenom
analysi
dna
viru
result
obtain
studi
may
differ
ng
workflow
sequenc
perform
neb
dna
librari
prep
kit
illumina
hiseq
system
studi
explor
influenc
differ
extract
method
metagenom
analysi
viral
nucleic
acid
use
divers
biolog
sampl
includ
human
fece
blood
tissu
contain
multipl
viral
agent
evalu
viral
nucleic
acid
extract
effici
differ
ng
qrtpcr
analysi
rpmk
applic
metagenom
analysi
viral
rna
enabl
sensit
identif
rna
viru
genom
respiratori
clinic
sampl
addit
viral
rna
extract
kit
also
applic
metagenom
analysi
dna
viru
result
highlight
import
nucleic
acid
extract
kit
select
major
impact
yield
number
viral
read
ng
analysi
therefor
choic
extract
method
given
viral
pathogen
need
care
consid
spike
mixtur
two
nasopharyng
aspir
specimen
contain
adv
flu
hmpv
pool
use
cador
pathogen
qiacub
ht
kit
qiagen
autom
viral
dna
rna
extract
qiacub
ht
system
presenc
viru
test
individu
qrtpcr
use
specif
primer
probe
target
differ
genom
ct
valu
adv
flu
hmpv
respect
ct
valu
invers
nucleic
acid
concentr
correl
number
copi
sampl
therefor
lower
ct
valu
abund
nucleic
acid
presenc
aliquot
mixtur
subject
subsequ
extract
duplic
n
use
four
commerci
avail
kit
four
commerci
avail
kit
vrmk
mvsk
rpmk
rmk
compar
use
simultan
isol
viral
dna
rna
even
though
kit
primarili
design
exclus
dna
rna
tabl
select
individu
kit
base
commerci
avail
literatur
report
rpmk
use
purif
total
rna
gdna
elimin
column
small
sampl
includ
anim
human
cell
tissu
microdissect
cryosect
rna
cleanup
concentr
major
differ
among
util
commerci
kit
differ
chaotrop
salt
deterg
addit
includ
lysi
buffer
mix
sampl
homogen
vortex
nucleic
acid
extract
parallel
aliquot
duplic
kit
accord
manufactur
instruct
process
absenc
viral
enrich
carrier
rna
use
extract
final
extract
nucleic
acid
elut
individu
n
volum
ave
buffer
rnasefre
water
follow
nucleic
acid
extract
four
kit
tabl
individu
perform
regard
yield
viral
nucleic
acid
compar
use
qrtpcr
specif
qrtpcr
protocol
individu
perform
duplic
n
viru
extract
n
use
real
time
pcr
system
appli
biosystem
quantif
adv
flu
hmpv
pcr
mixtur
consist
qrtpcr
buffer
mix
primerprob
set
enzym
mix
onestep
rtpcr
kit
appli
biosystem
qrtpcr
experi
perform
final
reaction
volum
contain
nucleic
acid
elut
follow
cycl
condit
min
min
cycl
prior
librari
process
yield
total
extract
nucleic
acid
quantifi
use
qubit
assay
kit
fluromet
dsdna
hs
assay
kit
invitrogen
highli
select
doublestrand
dna
design
accur
initi
sampl
concentr
rna
hs
assay
kit
invitrogen
design
accur
rna
sampl
concentr
viral
extract
n
subject
revers
transcript
pcr
amplif
eleven
microlit
elut
use
templat
total
volum
random
primer
dntp
mm
first
strand
buffer
dtt
superscript
iii
invitrogen
templat
random
primer
heat
min
follow
revers
transcript
min
inactiv
min
prior
second
strand
synthesi
cdna
denatur
min
cool
min
second
strand
synthes
u
klenow
fragment
exopolymeras
thermo
fisher
scientif
final
volum
incub
min
follow
enzym
inactiv
sequenc
librari
prepar
individu
indic
use
neb
dna
librari
prep
kit
illumina
neb
usa
follow
manufactur
recommend
index
code
ad
attribut
sequenc
sampl
briefli
dna
sampl
fragment
sonic
size
bp
dna
fragment
endpolish
atail
ligat
fulllength
adaptor
illumina
sequenc
pcr
amplif
cycl
final
pcr
product
purifi
ampur
xp
system
librari
analyz
size
distribut
agil
bioanalyz
quantifi
use
rtpcr
sequenc
perform
illumina
hiseq
system
output
bp
pairedend
read
cluster
indexcod
sampl
perform
cbot
cluster
gener
system
accord
manufactur
instruct
cluster
gener
librari
prepar
sequenc
illumina
platform
pairedend
read
gener
workflow
use
compar
perform
four
differ
commerci
avail
extract
kit
select
virus
ng
run
n
correspond
eight
extract
perform
parallel
raw
read
filter
remov
low
qualiti
sequenc
adapt
trimmomat
version
ngqc
version
qualiti
control
perform
read
compar
human
refer
genom
align
host
read
detect
use
soapalign
version
assess
taxonom
assign
result
read
sampl
align
viru
databas
juli
viral
protein
databas
ncbi
refseq
databas
juli
use
vip
analysi
softwar
version
sequenc
five
select
virus
ncbi
taxid
extract
ncbi
refseq
august
ncbint
august
databas
order
detect
select
virus
clean
read
sampl
map
subrefseq
genom
subnt
databas
sequenc
soapalign
version
final
sampl
read
map
speci
subnt
databas
assembl
contig
megahit
version
contig
map
subnt
databas
determin
taxonom
classif
addit
file
figur
upgma
unweight
pairgroup
method
arithmet
mean
analysi
eight
sampl
test
tree
repres
result
upgma
hierarch
cluster
weight
unifrac
distanc
matrix
extract
duplic
n
use
four
commerci
avail
kit
scale
bar
indic
distanc
cluster
unifrac
unit
four
differ
extract
kit
show
differ
group
eight
extract
figur
similar
differ
speci
phylum
commun
four
extract
kit
quantifi
upgma
cluster
analysi
base
weight
unifrac
distanc
metric
result
cluster
extract
kit
parallel
result
within
extract
kit
show
good
repeat
docx
kb
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
author
detail
